Last quarter (Q3 2025), Emergent Biosolutions's total revenue was $231.10M, an increase of 18.70% from the same quarter last year. In Q3, Emergent Biosolutions's net income was $51.20M. See Emergent Biosolutions’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 1.04B	$ 1.05B	$ 1.12B	$ 1.77B	$ 1.58B
Gross Profit	$ 375.40M	$ 360.00M	$ 473.00M	$ 793.20M	$ 863.10M
Operating Expenses	$ 484.10M	$ 1.09B	$ 643.00M	$ 451.80M	$ 424.60M
Depreciation and Amortization	$ 105.60M	$ 121.10M	$ 125.00M	$ 118.20M	$ 110.00M
EBITDA	$ 53.40M	$ -47.00M	$ 15.70M	$ 504.20M	$ 609.20M
Operating Income	$ -108.70M	$ -726.40M	$ -170.00M	$ 341.40M	$ 438.50M
Other Income/Expenses	$ -34.20M	$ -4.80M	$ -49.00M	$ -38.20M	$ -26.60M
Pretax Income	$ -142.90M	$ -731.20M	$ -219.00M	$ 303.20M	$ 411.90M
Net Income	$ -190.60M	$ -760.50M	$ -211.60M	$ 219.50M	$ 305.80M
Per Share Metrics
Basic EPS	$ -3.60	$ -14.85	$ -4.47	$ 4.10	$ 5.79
Diluted EPS	$ -3.60	$ -14.85	$ -4.47	$ 4.06	$ 5.67
Weighted Average Shares Outstanding	53.00M	51.20M	50.10M	53.50M	52.70M
Weighted Average Shares Outstanding (Diluted)	53.00M	51.20M	50.10M	54.10M	53.80M

Currency in USD

Emergent Biosolutions Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing